Healthcare Triangle Facilitated Secure Data Sharing for a Leading Pharmaceutical Company through Neutral ZoneTM, the Collaborative Data Platform
The Client
The Need
Our customer has a vast amount of data and is involved in several collaborative initiatives with other healthcare and pharmaceutical companies to create faster and personalized drug discovery. The pharma giant wanted to share data with a global biopharmaceutical company to develop highly personalized cancer treatments without sacrificing the security of that data or putting their intellectual properties (IP) at risk. They were looking for a solution that will be able to:
- Provide a secured IT architecture and infrastructure to support collaboration and data sharing between different entities adhering to compliance needs
- An interconnecting space that can adhere to every individual organization’s jurisdiction and legal requirements
- Get access to insights gathered by pooling individual organizations’ data together for analysis by artificial intelligence technology
Reasons for Choosing Healthcare Triangle
Healthcare Triangle (HCTI) has strong knowledge and exposure to all major products and services in the field of advanced analytics both in open source and enterprise products/solutions.
HCTI’s Neutral ZoneTM, the secure, and compliant data collaboration platform managed by DataEzTM performs collaborative research without sacrificing security of IP or PHI and access to a broad range of data for analysis—in days rather than months.
DataEzTM, the HIPAA-compliant and HITRUST certified AI engineering and analytics platform ensures robust access control and proactive monitoring of data while collaboration with life sciences and healthcare organizations – even with competitors to revolutionize drug discovery and personalized medicine.
The Solution
Using HCTI’s Neutral ZoneTM, under the collaboration with a global biopharmaceutical company, our client helped create an AI-based image analysis algorithm to aid pathologists in interpreting an on-market assay approved by the FDA that is used as a companion diagnostic for non-small cell lung cancer patients. Our customer used their recent open-environment collaboration to integrate an AI-powered algorithm for CD8 biomarker analysis.
Once the algorithm was created, it was used by the biopharmaceutical company for clinical trial samples to collect biomarker data which was then used to develop new cancer treatments, highly personalized to a patient’s biology and tumor makeup.
As a third party, HCTI’s Neutral ZoneTM gave both leaders, the ability to allow access to specific data only to the algorithm that will analyze the data for their research. It enabled the confidence in data sharing as these data with Neutral ZoneTM are essentially “shared but sealed.” The raw data are never disclosed, and data owners can control which portions of a data set are used and how they are used.
HCTI’s Neutral ZoneTM platform facilitated all analytics operations on the data with multiple layers of security without compromising on the agility. The platform provided the capacity for ingesting, processing, and gaining insights from data while ensuring security and compliance, self-cataloguing, and automated data quality checks.
AWS Integrations
Amazon Redshift:
HCTI’s Neutral ZoneTM uses Amazon Redshift to securely collaborate data among the clients. Using Amazon Redshift, HCTI reduced operational costs, shortened extract, transform, and load (ETL) times, and scaled operations for the customer.
Amazon QuickSight:
HCTI fully integrates QuickSight into Neutral ZoneTM to support advanced analytics and reporting at an unlimited scale for our customer. QuickSight’s deep security & services integration, and ML capabilities enabled HCTI to provide a seamless embedded analytics experience at a fraction of the total cost of ownership of other BI platforms.
The QuickSight dashboard allows secure access to interactive data and provides a 360-degree view of the patient/clinical data, expanding the use of data to improve patient care and accelerate drug discovery.
Business Benefits
HCTI’s Neutral ZoneTM platform supports access to a broad range of data—from both organizations from clinical trials—as well as data science capabilities in days rather than months. Some other business benefits include:
- Accelerated personalized medicine based on patient’s health problems
- Increased ease in establishing a foundation for cloud-based research
- Enhanced compliance with HIPAA, HITRUST, and more. Thus, able to
achieve collaborative research without sacrificing security of IP
or PHI - Greater flexibility and agility in establishing short-term and
long-term partnership arrangements for healthcare and clinical
discovery with fellow organizations